MOTOR PROFICIENCY in RELATION to COGNITIVE FUNCTIONS and SEVERITY in CHILDREN with AUTISM SPECTRUM DISORDERS

March 16, 2025 updated by: Aya Gamal Ali Abdelmoniem, Cairo University
To investigate the relationship between cognitive function, the severity of autism spectrum disorder (ASD), and the development of fine and gross motor skills in children with ASD

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A sample of 64 children with autism aged from 5 to 12 years recruited from centres and schools of special needs for intellectual and developmental disabilities to measure cognitive function using the Raven's Progressive Matrices and measure the severity of autism using the Childhood Autism Rating Scale (CARS). These assessments will then be compared with the children's fine and gross motor abilities

Study Type

Observational

Enrollment (Actual)

64

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Dokki
      • Cairo, Dokki, Egypt, 12613
        • Faculty of Physical Therapy Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

autistic children age ranged from 5 to 12 years

Description

Inclusion criteria:

  1. Children had been diagnosed with ASD.
  2. Their chronological age ranged from 5 years to 12 years.
  3. Intelligence quotient (IQ) ranged from 55 to 85.

Exclusion criteria:

Any child with the following criteria would be directly excluded from the evaluation for the consistency of the sample and statistically obtained results:

  1. The child with ASD and other motor disabilities.
  2. Visual or hearing impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
observational group
We will assess cognitive function using the Raven's Progressive Matrices and measure the severity of autism using the Childhood Autism Rating Scale (CARS). These assessments will then be compared with the children's fine and gross motor abilities using BOT2 .
Behavioral: measuring cognitive functions, severity of autism , gross and fine motor skills
measuring cognitive functions by RAVEN measuring severity by CARS measuring fine and gross motor functions by BOT2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
measuring motor proficiency (gross & fine motor skills ) by using BOT2 scale
Time Frame: 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
measuring cognitive functions by RAVEN Progressive matrices
Time Frame: 12 weeks
this scale items like puzzle and the child must extract the missed part from six choices
12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
measuring severity of autism by using CARS scale
Time Frame: 12 weeks
this scale like questionnaire consisted of 15 question and parents or teacher give answers to this questions
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Investigators

  • Study Chair: Heba Kamal professor, professor of physical therapy, Cairo University
  • Study Director: Alaa fahmy hassan El Nemer, lecturer of physical therapy, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Actual)

June 1, 2024

Study Completion (Actual)

August 1, 2024

Study Registration Dates

First Submitted

February 27, 2025

First Submitted That Met QC Criteria

March 16, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 16, 2025

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/005056

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on measuring cognitive functions, severity of autism , gross and fine motor skills

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe